Inventor · disambiguated record
Neil Derek Miller
Also filed as: MILLER NEIL · MILLER NEIL D · MILLER NEIL DEREK
9 granted patents·11 pending applications·46 citations·filing 2001–2025
85Inventor score
Files withGLAXO GROUP LTD10NRG THERAPEUTICS LTD4GIBLIN GERARD M P2SMITHKLINE BEECHAM CORP2CONGREVE MILES S1
Top patents by PatentIndex Score
20 records- 0185US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 0283US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 0383US7732622B2Naphthalene derivativesGLAXO GROUP LTD·Filed 2008·Granted Jun 8, 2010·5 cites·3 claims
- 0481US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 0574US7718689B2Benzoisoindole derivatives and their use as EP4 receptor ligandsGLAXO GROUP LTD·Filed 2007·Granted May 18, 2010·2 cites·16 claims
- 0670US7446222B2Phenyl compoundsGLAXO GROUP LTD·Filed 2003·Granted Nov 4, 2008·8 cites·9 claims
- 0763US6924297B2Naphathalene derivatives which bind to the EP4 receptorSMITHKLINE BEECHAM CORP·Filed 2001·Granted Aug 2, 2005·2 cites·13 claims
- 0855US2007088068A1Benzo[F]Isoindole Derivatives With Affinity To The EP4 ReceptorCONGREVE MILES S·Filed 2006·Application pending·0 cites
- 0949US2025179028A1Acrylamide compoundsNRG THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1048US12491185B2Inhibitors of mPTPNRG THERAPEUTICS LTD·Filed 2025·Granted Dec 9, 2025·0 cites·30 claims
- 1146US2007072906A1Pyrrole compoundsGIBLIN GERARD M P·Filed 2004·Application pending·0 cites
- 1245US2007232657A1Novel compoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 1345US2008275053A1Heterocyclyl CompoundsGLAXOSMITHKLINE·Filed 2004·Application pending·0 cites
- 1444US2009012056A1Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 ReceptorGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 1541US12497359B2Acrylamide derivativesNRG THERAPEUTICS LTD·Filed 2021·Granted Dec 16, 2025·0 cites·17 claims
- 1641US2007082912A1Pyrrole compounds for the treatment of prostaglandine mediated diseasesGIBLIN GERARD M P·Filed 2003·Application pending·0 cites
- 1741US2024067614A1Novel compoundsNRG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1841US2008318933A15-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns DisordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 1940US2007191345A13-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2038US2007225340A1Phenyl Compounds And Their Use In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 ReceptorGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil Derek Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →